Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Gro Biosciences Inc.

Headquarters: Cambridge, MA, United States of America
Year Founded: 2016
Status: Private

BioCentury | Jul 25, 2024
Finance

Venture Report: Third Arc’s $165M series A; Brenig heads for clinic with $65M round

Plus: Flagship-backed Abiologics launches; and rounds for GRO, Autobahn and Rona
BioCentury | Mar 19, 2024
Management Tracks

Syndax names new commercial head

Plus: Everest hires Sandra Zeng as CMO and Rico Liang as chief product officer, and updates from Parexel, Dignify and GRO
BioCentury | Nov 17, 2021
Management Tracks

Rhee steps down as CEO of Korea’s SCM

Recludix, Ankyra unveil venture rounds and new execs; plus ImmunoGen, Talis, Kira, Sonoma, Spruce, Ankyra and more
BioCentury | Nov 4, 2021
Product Development

Nov. 3 Quick Takes: Flagship, CF Foundation forming start-up

Plus Antios raises, Novo Nordisk misses, GRObio, Prilenia and more
BioCentury | Sep 29, 2017
Financial News

GRO Biosciences launches with $2.1M seed funding

BioCentury | Sep 28, 2017
Company News

GRO Biosciences launches with $2.1M seed funding

Items per page:
1 - 6 of 6